cytarabine has been researched along with ag-1296 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagrintseva, K; Eichenlaub, S; Ellwart, JW; Hiddemann, W; Kohl, TM; Schnittger, S; Schwab, R; Spiekermann, K | 1 |
| Böhmer, FD; Kirsch, C; Klinger, R; Scholl, S | 1 |
| Jawad, M; Mony, U; Pallis, M; Russell, N; Seedhouse, C | 1 |
3 other study(ies) available for cytarabine and ag-1296
| Article | Year |
|---|---|
Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoietic cells.
Topics: Acute Disease; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Transformed; Cytarabine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Genistein; Humans; Indoles; Leukemia, Myeloid; MAP Kinase Signaling System; Milk Proteins; Mutagenesis; Phenotype; Phosphorylation; Protein Structure, Tertiary; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; STAT5 Transcription Factor; Staurosporine; Trans-Activators; Tyrphostins | 2004 |
Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytarabine; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid; Phosphatidylinositol 3-Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-kit; Receptor Protein-Tyrosine Kinases; Stem Cell Factor; Tyrphostins | 2004 |
Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment.
Topics: ADP-ribosyl Cyclase 1; Antigens, CD34; Cell Line, Tumor; Cell Survival; Cytarabine; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Humans; Interleukin-3 Receptor alpha Subunit; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Neoplastic Stem Cells; Phenotype; Receptors, Interleukin-3; Tyrphostins | 2008 |